image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Synergy Healthcare - In the running for more PFI contracts

May 2004

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SYR
The shares went to an all-time high following a confident statement which noted that trading in the second half of the year ending March had beaten management's expectations. Broker, Brewin Dolphin, respondedby upgrading pretax profit forecasts 4% to £4m (11.8p eps) and 8% to £4.8m (14.1p eps) for the current year. The surgical side (60% sales) is benefiting from new contract starts and from the government's recent introduction of Independent Sector Treatment Centres (ISTC),  a new government initiative to reduce patient waiting times.  Synergy is also in talks regarding another 4-5 PFI schemes, although the selection of the preferred bidder for the Leeds/Bradford Pathfinder contract (in which Synergy is one of ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X